.svg){kind=small}
As an in vitro diagnostic (IVD) raw materials supplier, Medix Biochemica’s offering is both broad and deep. Since our establishment in the 1980s, our IVD offering has expanded to become the extensive portfolio our global customers rely on today.
In 2019, we offered monoclonal antibodies (mAbs) across a few key clinical areas. Today, in 2025, our range of 5 000 IVD products includes antibodies, antigens, biospecimens, base matrices, clinical enzymes and molecular diagnostic reagents – and covers several analytes and clinical areas within each of those product types too. Most recently, in January 2025, we’ve expanded to also offer premium immunoassay blockers and stabilizers. This growth is largely thanks to numerous strategic acquisitions we’ve made over the years.1,2
A timeline of Medix Biochemica’s growth
Here’s a look at how we’ve grown since 1985, and how each acquisition along the way has helped us to achieve the broad offering now available to our customers.2
Get in touch with our skilled support team today with any questions about our IVD product offering
1985: Founded in Finland by Finnish scientist Jim Schröder, who later became a Professor at the University of Helsinki3
2000–2010: ISO 9001, ISO 13485 and FDA QSR compliance achieved2
Read more: Our IVD Certifications and Quality Assurance
2010: MedixMAB services and MedixAntigens established3
2016: Medix Biochemica China established2
2018: Medix Biochemica USA established2
2019: Acquisition of Lee Biosolutions, adding antigens, clinical enzymes and biospecimens to our portfolio2
Read more: Medix Biochemica has Completed the Acquisition of Lee Biosolutions
2020: Acquisition of EastCoast Bio and Biostride, expanding our offerings in the areas of drugs of abuse, veterinary biomarkers and infectious diseases.2
Read more:
Infectious Diseases
Medix Biochemica Acquires US Firms EastCoast Bio, Biostride
2021: MedixMDx (molecular diagnostics) established2
Read more: MedixMDx Raw Materials for Molecular Biology Applications
2021: Acquisition of Diaclone, building expertise in inflammation and immuno-oncology2
Read more: Diaclone is Now Part of Medix Biochemica
2022: Acquisition of myPOLS Biotec GmbH and Bioresource Technology, adding base matrices to our quality-control portfolio and expanding into molecular diagnostic raw materials2
Read more:
Medix Biochemica Acquires myPOLS Biotec
Medix Biochemica Acquires IVD Raw Materials Producer Bioresource Technology
| Notable achievement: Our polymerase chain reaction (PCR) enzyme and master mix capabilities enabled clinical laboratories and test manufacturers to develop high-performing assays to detect SARS-CoV-2 (COVID-19) without the need for sample extraction or lysis, thereby saving hands-on time and consumables in the laboratory.2 |
2023: Acquisition of ViroStat, expanding our antigen and antibody offerings for infectious diseases2
Read more: Medix Biochemica Acquires ViroStat
2025: Acquisition of CANDOR Bioscience, adding premium immunoassay blockers and stabilizers to our portfolio2
Read more: Medix Biochemica Acquires CANDOR Bioscience
Why choose Medix Biochemica?
These are the key benefits of having a broad IVD offering:1
- We can be a one-stop provider for IVD customers around the world
- We can reliably and consistently meet the diverse needs of a large customer base
- We can navigate potential supply chain issues, minimizing disruption to customer production processes
Read more: IVD Raw Materials: The Advantages of a Broad Offering
With Medix Biochemica’s 5 000 IVD raw materials and more than four decades of experience, partnering with us is an easy way to meet – and even exceed – your company’s IVD requirements.
References:
- Expert opinion. Anthony Austin. Global Marketing Manager, Medix Biochemica. March 2025.
- Medix Biochemica across the world. Medix Biochemica blog. Accessed March 6, 2025. https://articles.medixbiochemica.com/medix-biochemica-across-the-world.
- The History of Medix Biochemica. Medix Biochemica blog. Accessed March 6, 2025. https://articles.medixbiochemica.com/the-history-of-medix-biochemica.
